Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary

JAMA Intern Med. 2020 Mar 1;180(3):454-456. doi: 10.1001/jamainternmed.2019.5337.


This study examines the estimated cost of asthma inhalers for individuals treated under Medicare Part B compared with those treated under the Veterans Affairs Health System, taking into account separate approaches to price negotiation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost Savings*
  • Drug Costs*
  • Humans
  • Medicare Part D / economics*
  • Nebulizers and Vaporizers / economics*
  • Prescriptions
  • United States